Former Republican Sen. Burr suggested that the White House may temper some of the anti-pharma policies embraced by Trump's HHS nominees. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
